Biomimetic proteolipid vesicles for targeting inflamed tissues

R. Molinaro, C. Corbo, J. O. Martinez, F. Taraballi, M. Evangelopoulos, S. Minardi, I. K. Yazdi, P. Zhao, E. De Rosa, Michael Sherman, A. De Vita, N. E. Toledano Furman, X. Wang, A. Parodi, E. Tasciotti

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles - which we refer to as leukosomes - retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.

Original languageEnglish (US)
Pages (from-to)1037-1046
Number of pages10
JournalNature Materials
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Proteolipids
biomimetics
Biomimetics
delivery
Tissue
Nanoparticles
Cell membranes
Drug delivery
Drug products
Dexamethasone
leukocytes
nanoparticles
microparticles
versatility
Proteins
vessels
lipids
drugs
Pharmaceutical Preparations
membranes

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., ... Tasciotti, E. (2016). Biomimetic proteolipid vesicles for targeting inflamed tissues. Nature Materials, 15(9), 1037-1046. https://doi.org/10.1038/nmat4644

Biomimetic proteolipid vesicles for targeting inflamed tissues. / Molinaro, R.; Corbo, C.; Martinez, J. O.; Taraballi, F.; Evangelopoulos, M.; Minardi, S.; Yazdi, I. K.; Zhao, P.; De Rosa, E.; Sherman, Michael; De Vita, A.; Toledano Furman, N. E.; Wang, X.; Parodi, A.; Tasciotti, E.

In: Nature Materials, Vol. 15, No. 9, 01.09.2016, p. 1037-1046.

Research output: Contribution to journalArticle

Molinaro, R, Corbo, C, Martinez, JO, Taraballi, F, Evangelopoulos, M, Minardi, S, Yazdi, IK, Zhao, P, De Rosa, E, Sherman, M, De Vita, A, Toledano Furman, NE, Wang, X, Parodi, A & Tasciotti, E 2016, 'Biomimetic proteolipid vesicles for targeting inflamed tissues', Nature Materials, vol. 15, no. 9, pp. 1037-1046. https://doi.org/10.1038/nmat4644
Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S et al. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nature Materials. 2016 Sep 1;15(9):1037-1046. https://doi.org/10.1038/nmat4644
Molinaro, R. ; Corbo, C. ; Martinez, J. O. ; Taraballi, F. ; Evangelopoulos, M. ; Minardi, S. ; Yazdi, I. K. ; Zhao, P. ; De Rosa, E. ; Sherman, Michael ; De Vita, A. ; Toledano Furman, N. E. ; Wang, X. ; Parodi, A. ; Tasciotti, E. / Biomimetic proteolipid vesicles for targeting inflamed tissues. In: Nature Materials. 2016 ; Vol. 15, No. 9. pp. 1037-1046.
@article{4be754016df64c87bdbc0c10086ace81,
title = "Biomimetic proteolipid vesicles for targeting inflamed tissues",
abstract = "A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles - which we refer to as leukosomes - retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.",
author = "R. Molinaro and C. Corbo and Martinez, {J. O.} and F. Taraballi and M. Evangelopoulos and S. Minardi and Yazdi, {I. K.} and P. Zhao and {De Rosa}, E. and Michael Sherman and {De Vita}, A. and {Toledano Furman}, {N. E.} and X. Wang and A. Parodi and E. Tasciotti",
year = "2016",
month = "9",
day = "1",
doi = "10.1038/nmat4644",
language = "English (US)",
volume = "15",
pages = "1037--1046",
journal = "Nature Materials",
issn = "1476-1122",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Biomimetic proteolipid vesicles for targeting inflamed tissues

AU - Molinaro, R.

AU - Corbo, C.

AU - Martinez, J. O.

AU - Taraballi, F.

AU - Evangelopoulos, M.

AU - Minardi, S.

AU - Yazdi, I. K.

AU - Zhao, P.

AU - De Rosa, E.

AU - Sherman, Michael

AU - De Vita, A.

AU - Toledano Furman, N. E.

AU - Wang, X.

AU - Parodi, A.

AU - Tasciotti, E.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles - which we refer to as leukosomes - retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.

AB - A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles - which we refer to as leukosomes - retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84969883853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969883853&partnerID=8YFLogxK

U2 - 10.1038/nmat4644

DO - 10.1038/nmat4644

M3 - Article

C2 - 27213956

AN - SCOPUS:84969883853

VL - 15

SP - 1037

EP - 1046

JO - Nature Materials

JF - Nature Materials

SN - 1476-1122

IS - 9

ER -